MedTrace Logo

Attentional Re-training for Chronic Pain Patients

NCT04150419 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2022-12-19

No results posted yet for this study

Summary

Hyper-vigilance, focusing, avoidance are part of the vocabulary used by the clinician who deals with chronic pain. These notions refer to the functioning and dysfunction of so-called "selective" attention. These "selective attentional biases" are believed to be responsible, in part, for the development and maintenance of negative pain-related thoughts (such as catastrophic thoughts), inappropriate behaviours (such as inactivity and fear of movement) and unpleasant emotions (such as stress or anger). In addition, they would also be a powerful indicator of the onset of post-operative pain and could limit the effectiveness of therapeutic management. Therapeutically, attention bias can be "managed" through attentional re-training techniques (ABMs) that teach patients to direct their attention differently. These techniques have been widely validated in anxious or addictive populations but have never been used to date in chronic pain patients. This home-based attention bias management (e-retraining) would represent, for chronic pain patients, an additional tool aimed not only at reducing their pain but also at achieving other associated factors such as anxiety, stress, catastrophic thoughts, avoidance behaviours and quality of life.

Conditions

  • Chronic Pelvic Perinal Pain

Interventions

OTHER

Group 1

Attentional training to avoid threatening, negative or pain-related information.

OTHER

Group 2

Attention training for vigilance for positive emotional information.

OTHER

Group 3 (control group)

Neutral attentional training (control group).

Sponsors & Collaborators

  • Fondation Apicil

    collaborator OTHER

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Virginie Quistrebert-Davanne, PhD · Nantes University Hospital Nantes

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2022-12-06
Completion
2022-12-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04150419 on ClinicalTrials.gov